Fibrobiologics Common Stock Stock Alpha and Beta Analysis
| FBLG Stock | 0.39 0.05 13.32% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as FibroBiologics Common Stock. It also helps investors analyze the systematic and unsystematic risks associated with investing in FibroBiologics Common over a specified time horizon. Remember, high FibroBiologics Common's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to FibroBiologics Common's market risk premium analysis include:
Beta 1.28 | Alpha (0.28) | Risk 8.89 | Sharpe Ratio 0.0292 | Expected Return 0.26 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
FibroBiologics | Build AI portfolio with FibroBiologics Stock |
FibroBiologics Common Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. FibroBiologics Common market risk premium is the additional return an investor will receive from holding FibroBiologics Common long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FibroBiologics Common. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate FibroBiologics Common's performance over market.| α | -0.28 | β | 1.28 |
FibroBiologics Common expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of FibroBiologics Common's Buy-and-hold return. Our buy-and-hold chart shows how FibroBiologics Common performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.FibroBiologics Common Market Price Analysis
Market price analysis indicators help investors to evaluate how FibroBiologics Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroBiologics Common shares will generate the highest return on investment. By understating and applying FibroBiologics Common stock market price indicators, traders can identify FibroBiologics Common position entry and exit signals to maximize returns.
FibroBiologics Common Return and Market Media
The median price of FibroBiologics Common for the period between Tue, Oct 14, 2025 and Mon, Jan 12, 2026 is 0.34 with a coefficient of variation of 22.35. The daily time series for the period is distributed with a sample standard deviation of 0.08, arithmetic mean of 0.34, and mean deviation of 0.06. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | FibroBiologics Receives HREC Approval for Phase 12 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers | 11/20/2025 |
2 | FibroBiologics Announces 1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 11/24/2025 |
3 | FibroBiologics Announces Payoff of Outstanding Debt | 11/26/2025 |
4 | FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions | 12/10/2025 |
5 | Acquisition by Ruben Garcia of 140000 shares of FibroBiologics, Common at 0.34 subject to Rule 16b-3 | 12/11/2025 |
6 | FibroBiologics Announces 1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 12/15/2025 |
7 | FibroBiologics Announces Closing of 1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | 12/16/2025 |
8 | FibroBiologics Inc. Sees Significant Decrease in Short Interest | 12/29/2025 |
9 | FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte Spheroid Therapy for Degenerative Disc Disease | 01/05/2026 |
10 | FBLG Phase 12 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 | 01/08/2026 |
About FibroBiologics Common Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including FibroBiologics or other stocks. Alpha measures the amount that position in FibroBiologics Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
FibroBiologics Common Investors Sentiment
The influence of FibroBiologics Common's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in FibroBiologics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to FibroBiologics Common's public news can be used to forecast risks associated with an investment in FibroBiologics. The trend in average sentiment can be used to explain how an investor holding FibroBiologics can time the market purely based on public headlines and social activities around FibroBiologics Common Stock. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
FibroBiologics Common's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for FibroBiologics Common's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average FibroBiologics Common's news discussions. The higher the estimated score, the more favorable is the investor's outlook on FibroBiologics Common.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FibroBiologics Common in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FibroBiologics Common's short interest history, or implied volatility extrapolated from FibroBiologics Common options trading.
Build Portfolio with FibroBiologics Common
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out FibroBiologics Common Backtesting, FibroBiologics Common Valuation, FibroBiologics Common Correlation, FibroBiologics Common Hype Analysis, FibroBiologics Common Volatility, FibroBiologics Common History and analyze FibroBiologics Common Performance. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
FibroBiologics Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.